Menu
Recruiting NCT06746805

The Effect of Acute Ketone Monoester Supplementation on Glucose Oxidation During Exercise

No phase Interventional Exercise Metabolism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: CHO+KETONE, CHO+PLACEBO.
Who it may be relevant to
Registry conditions: Exercise Metabolism. Basic parameters: 18 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Acute Ketone Monoester Supplementation on Glucose Oxidation During Exercise Performed With High Rates of Carbohydrate Ingestion in Trained Cyclists

Overview

The purpose of this study is to examine the effect of exogenous ketone body supplementation on carbohydrate metabolism during exercise. In a randomized, crossover, and double-blind study, 20 endurance trained adult males and females aged 18-50 years, will ingest carbohydrates with either a ketone monoester supplement before and throughout a 3-hour exercise session or carbohydrates with a flavour-matched ketone-free placebo. The main aim of this study is to compare the exogenous carbohydrate oxidation rates during exercise between the ketone monoester and placebo conditions.

Interventions

  • Dietary supplement CHO+KETONE
    Sports drink containing glucose and ketone mono-esters
  • Dietary supplement CHO+PLACEBO
    Sports drink containing glucose and placebo

Primary outcome measures

  • Exogenous carbohydrate oxidation rate [Time frame: Acute:during 3 hours of exercise]
Secondary outcome measures (7)
  • Endogenous carbohydrate disappearance rate [Time frame: Acute:during 3 hours of exercise]
  • Exogenous carbohydrate disappearance rate [Time frame: Acute:during 3 hours of exercise]
  • Total carbohydrate disappearance rate [Time frame: Acute:during 3 hours of exercise]
  • Exogenous carbohydrate appearance rate [Time frame: Acute:during 3 hours of exercise]
  • Endogenous carbohydrate appearance rate [Time frame: Acute:during 3 hours of exercise]
  • Total carbohydrate appearance rate [Time frame: Acute:during 3 hours of exercise]
  • Plasma glucose enrichments during exercise [Time frame: Acute:during 3 hours of exercise]

Eligibility criteria

Inclusion criteria

  • 18-50 years of age
  • Trained cyclist/triathlete (VO2peak > 55 ml/kg/min for males and >48 ml/mg/min for females)
  • Healthy as per medical history and investigator's/physician's judgement
  • Having given written informed consent

Exclusion criteria

  • Use of medication that could impact study outcomes and/or interfere with the expected mechanism of action of ketone supplements (e.g. Chronic use of gastric acid suppressing medication, statins, corticosteroids)
  • Smoking
  • Diagnosed acute or chronic medical conditions that, in the opinion of the investigator, could impact study outcomes (e.g. Diabetes mellitus)
  • Diagnosed musculoskeletal disorders
  • Adhering to a carbohydrate restrictive diet
  • Participation in another study at the same time
  • Blood donation in the 2 months before the first experimental trial
  • Plasma donation in the 2 weeks before the first experimental trial
  • Males: VO2peak <55 ml/min/kg body mass
  • Females: VO2peak <48 ml/min/kg body mass
  • Females: pregnancy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Triple blind
Primary purpose
Other

Study locations

Netherlands · 1 center
  • Maastricht University Medical Center+ — Maastricht

Identifiers

NCT: NCT06746805 · METC 23-001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗